Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Screening outcomes from patients with suspected multidrug-resistant tuberculosis: lessons learned in the Philippines.

Gler MT, Guilatco RS, Guray CV, Tupasi TE.

Int J Tuberc Lung Dis. 2012 Oct;16(10):1326-30. doi: 10.5588/ijtld.12.0038.

PMID:
22863522
2.

Multidrug-resistant tuberculosis among previously treated patients in the Philippines.

Gler MT, Macalintal LE, Raymond L, Guilatco R, Quelapio MI, Tupasi TE.

Int J Tuberc Lung Dis. 2011 May;15(5):652-6. doi: 10.5588/ijtld.10.0400.

PMID:
21756517
3.

Tuberculosis drug resistance and treatment outcomes under DOTS settings in large cities in the Philippines.

Ohkado A, Aguiman L, Adlawan S, Baring E, Quirante O, Suchi M, Endo S, Fujiki A, Mori T.

Int J Tuberc Lung Dis. 2006 Mar;10(3):283-9.

PMID:
16562708
5.

Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.

Mendoza MT, Gonzaga AJ, Roa C, Velmonte MA, Jorge M, Montoya JC, Tan Torres T, Ong M, Barez MY, Ang CF.

Int J Tuberc Lung Dis. 1997 Feb;1(1):59-63.

PMID:
9441060
6.

[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].

Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.

Kekkaku. 2003 Oct;78(10):611-7. Japanese.

PMID:
14621568
7.

First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.

Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC.

Int J Tuberc Lung Dis. 2012 Jun;16(6):805-11. doi: 10.5588/ijtld.11.0522.

PMID:
22390880
8.

Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.

Tabarsi P, Chitsaz E, Tabatabaei V, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Mansouri D, Masjedi MR, Velayati AA.

Am J Ther. 2011 Sep;18(5):343-9. doi: 10.1097/MJT.0b013e3181dd60ec.

PMID:
20535008
9.

Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.

Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, Paramasivan CN, Narayanan PR, Sahu S, Parmar M, Chadha S, Dewan P, Chauhan LS.

Int J Tuberc Lung Dis. 2009 Sep;13(9):1154-60.

PMID:
19723407
10.

The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.

Seddon JA, Hesseling AC, Marais BJ, Jordaan A, Victor T, Schaaf HS.

Int J Tuberc Lung Dis. 2012 Jul;16(7):928-33. doi: 10.5588/ijtld.11.0679.

PMID:
22583610
11.

National anti-tuberculosis drug resistance study in Tanzania.

Chonde TM, Basra D, Mfinanga SG, Range N, Lwilla F, Shirima RP, van Deun A, Zignol M, Cobelens FG, Egwaga SM, van Leth F.

Int J Tuberc Lung Dis. 2010 Aug;14(8):967-72.

PMID:
20626940
13.

Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.

Liang L, Wu Q, Gao L, Hao Y, Liu C, Xie Y, Sun H, Yan X, Li F, Li H, Fang H, Ning N, Cui Y, Han L.

Thorax. 2012 Jul;67(7):632-8. doi: 10.1136/thoraxjnl-2011-200018.

PMID:
22403070
14.

[Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].

Augustynowicz-Kopeć E, Zwolska Z, Jaworski A, Kostrzewa E, Klatt M, Swiderska A, Drozd I.

Pneumonol Alergol Pol. 2002;70(3-4):193-202. Polish.

PMID:
12271966
15.

Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.

Chien JY, Lai CC, Tan CK, Chien ST, Yu CJ, Hsueh PR.

J Antimicrob Chemother. 2013 Aug;68(8):1910-6. doi: 10.1093/jac/dkt103.

16.

Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.

Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE.

Int J Tuberc Lung Dis. 2000 Feb;4(2):108-14.

PMID:
10694087
17.

Multi-drug resistant tuberculosis burden and risk factors: an update.

Marahatta SB.

Kathmandu Univ Med J (KUMJ). 2010 Jan-Mar;8(29):116-25. Review.

PMID:
21209520
18.

Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.

Reechaipichitkul W.

Southeast Asian J Trop Med Public Health. 2002 Sep;33(3):570-4.

PMID:
12693593
19.

Drug resistance among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam.

Quy HT, Buu TN, Cobelens FG, Lan NT, Lambregts CS, Borgdorff MW.

Int J Tuberc Lung Dis. 2006 Feb;10(2):160-6.

PMID:
16499254
20.

The national tuberculosis drug resistance survey in Cambodia, 2000-2001.

Yamada N, Saorith K, Yamakami K, Onozaki I, Boran S, Fujiki A, Eang MT, Mori T.

Int J Tuberc Lung Dis. 2007 Dec;11(12):1321-7.

PMID:
18034953
Items per page

Supplemental Content

Support Center